ChiCTR2300068048 版本V1.0 版本创建时间2023/02/05 20:12:08 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300068048 

最近更新日期:

Date of Last Refreshed on:

2023-02-05 20:11:32 

注册时间:

Date of Registration:

2023-02-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

长蛇灸联合盆底肌训练改善肾阳虚型压力性尿失禁患者BND、PUVA的研究

Public title:

Effect of long snake moxibustion combined with pelvic floor muscle training on BND and PUVA in patients with stress urinary incontinence of kidney-yang deficiency type

注册题目简写:

English Acronym:

研究课题的正式科学名称:

长蛇灸联合盆底肌训练改善肾阳虚型压力性尿失禁患者BND、PUVA的研究

Scientific title:

Effect of long snake moxibustion combined with pelvic floor muscle training on BND and PUVA in patients with stress urinary incontinence of kidney-yang deficiency type

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

朱小燕 

研究负责人:

朱小燕 

Applicant:

Zhu Xiaoyan 

Study leader:

Zhu Xiaoyan 

申请注册联系人电话:

Applicant telephone:

13732934433

研究负责人电话:

Study leader's
telephone:

13732934433

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

498833527@qq.com

研究负责人电子邮件:

Study leader's E-mail:

498833527@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江西省南昌市红谷滩区碟子湖大道1399号

研究负责人通讯地址:

江西省南昌市红谷滩区碟子湖大道1399号

Applicant address:

No. 1399, Diezihu Avenue, Honggu Tan District, Nanchang City, Jiangxi Province

Study leader's address:

No. 1399, Diezihu Avenue, Honggu Tan District, Nanchang City, Jiangxi Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南昌市洪都中医院

Applicant's institution:

Nanchang Hongdu Hospital of TCM

研究负责人所在单位:

南昌市洪都中医院

Affiliation of the Leader:

Nanchang Hongdu Hospital of TCM

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY-2022-009

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南昌市洪都中医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Nanchang Hongdu Hospital of TCM

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-15 00:00:00

伦理委员会联系人:

何菲

Contact Name of the ethic committee:

He fei

伦理委员会联系地址:

江西省南昌市红谷滩区碟子湖大道1399号

Contact Address of the ethic committee:

No. 1399, Diezihu Avenue, Honggu Tan District, Nanchang City, Jiangxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 793 83863120

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南昌市洪都中医院

Primary sponsor:

Nanchang Hongdu Hospital of TCM

研究实施负责(组长)单位地址:

江西省南昌市红谷滩新区碟子湖大道1399号

Primary sponsor's address:

No. 1399, Diezihu Avenue, Honggu Tan District, Nanchang City, Jiangxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江西

市(区县):

南昌

Country:

China

Province:

Jiangxi

City:

Nanchang

单位(医院):

南昌市洪都中医院

具体地址:

江西省南昌市红谷滩新区碟子湖大道1399号

Institution
hospital:

Nanchang Hongdu Hospital of TCM

Address:

1399 Diezihu Avenue, Honggu Tan District, Nanchang, Jiangxi

经费或物资来源:

南昌市科技支撑计划项目

Source(s) of funding:

Nanchang Science and Technology Support Program

研究疾病:

压力性尿失禁  

Target disease:

Stress urinary incontinence

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

观察长蛇灸联合盆底肌训练对肾阳虚型压力性尿失禁患者BND、PUVA的影响  

Objectives of Study:

To observe the effect of long snake moxibustion combined with pelvic floor muscle training on BND and PUVA in patients with stress urinary incontinence of kidney-yang deficiency type

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①符合压力性尿失禁诊断标准;
②年龄在30-60岁的经产妇患者;
③轻中度压力性尿失禁;
④自愿参加研究并签署知情同意书;
⑤近1个月未针对该病进行治疗或服用影响下尿路功能的药物;

Inclusion criteria

1. Meet the diagnostic criteria of appeal; 2. Multiparous women aged 30-60 years; 3. Mild to moderate stress urinary incontinence; 4. Voluntarily participate in the study and sign the informed consent form; 5. No treatment for the disease or take drugs affecting lower urinary tract function in the past 1 month;

排除标准:

①不符合上述纳入标准的其他病例;②妊娠或月经期妇女;③既往有盆腔手术史者。④合并泌尿系统或盆底急性感染、膀胱结石或肿瘤以及神经源性膀胱,不稳定性膀胱或急迫性尿失禁;⑤合并有严重的心脑血管、肝、肾及神经系统等严重疾病及精神障碍患者。⑥盆底感知障碍,不能配合诊疗者。

Exclusion criteria:

1. Other cases that do not meet the above inclusion criteria; 2. Pregnant or menstrual women; 3. Previous pelvic surgery history. 4. Combined with acute urinary system or pelvic floor infection, bladder stones or tumors and neurogenic bladder, unstable bladder or urge urinary incontinence; 5. Combined with severe cardiovascular and cerebrovascular, liver, kidney and nervous system and other serious diseases and mental disorders. 6 Pelvic floor perception disorder, unable to cooperate with the diagnosis and treatment.

研究实施时间:

Study execute time:

From 2021-07-01 00:00:00 To 2023-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-02-05 00:00:00 To 2023-05-01 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

45

Group:

Observation group

Sample size:

干预措施:

长蛇灸联合盆底肌训练

干预措施代码:

Intervention:

Long snake moxibustion combined with pelvic floor muscle training

Intervention code:

组别:

对照组

样本量:

45

Group:

Control group

Sample size:

干预措施:

盆底肌训练

干预措施代码:

Intervention:

Pelvic floor muscle training

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江西 

市(区县):

南昌 

Country:

China

Province:

Jiangxi

City:

Nanchang

单位(医院):

南昌市洪都中医院 

单位级别:

三级甲等 

Institution
hospital:

Nanchang Hongdu Hospital of TCM

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

1h 尿垫试验

指标类型:

主要指标

Outcome:

1h urine pad test

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

尿失禁影响问卷简表

指标类型:

主要指标

Outcome:

incontinence impact questionnaire short form

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

膀胱颈移动度和膀胱尿道后角的数值

指标类型:

主要指标

Outcome:

Values of bladder neck mobility and posterior vesicourethral angle

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 30 years
最大 Max age 60 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

研究者将符合本课题纳入标准的90例研究对象随机分为观察组和对照组,每组研究对象各45例;根据随机数字表制作随机分配卡片,密封于信封中,信封上写上编号,由专人保管,当合格受试者选入研究时,将调查对象编号,再打开相应编号的信封,按照信封内卡片上的方案进行治疗。

Randomization Procedure (please state who generates the random number sequence and by what method):

The investigator randomly divided 90 subjects who met the inclusion criteria into the study group and the control group, 45 subjects in each group. The random allocation card was made according to the random number table, sealed in an envelope, written with a number on the envelope, and kept by a

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

2024年

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

2024

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2023-02-05 20:11:32